| Analysis | Metabolite Name | Measured Value | Units | Genotype | Treatment |
|---|---|---|---|---|---|
| Reversed phase UNSPECIFIED ION MODE | FA170 | 948.8098946 | intensity | Wild-type | LPS+antiPla2g5 |
| Reversed phase UNSPECIFIED ION MODE | FA170 | 1017.238048 | intensity | Wild-type | LPS+antiPla2g5 |
| Reversed phase UNSPECIFIED ION MODE | FA170 | 1028.262596 | intensity | Wild-type | LPS+antiPla2g5 |
| Reversed phase UNSPECIFIED ION MODE | FA170 | 1053.399518 | intensity | Wild-type | LPS+antiPla2g5 |
| Reversed phase UNSPECIFIED ION MODE | FA170 | 1184.443013 | intensity | Wild-type | LPS |
| Reversed phase UNSPECIFIED ION MODE | FA170 | 1185.412941 | intensity | Wild-type | LPS |
| Reversed phase UNSPECIFIED ION MODE | FA170 | 1232.403329 | intensity | Wild-type | LPS+antiPla2g5 |
| Reversed phase UNSPECIFIED ION MODE | FA170 | 1274.245483 | intensity | Wild-type | LPS |
| Reversed phase UNSPECIFIED ION MODE | FA170 | 1460.453999 | intensity | Wild-type | LPS+antiPla2g5 |
| Reversed phase UNSPECIFIED ION MODE | FA170 | 1490.153846 | intensity | Wild-type | LPS |
| Reversed phase UNSPECIFIED ION MODE | FA170 | 1592.321408 | intensity | Wild-type | LPS+antiPla2g5 |
| Reversed phase UNSPECIFIED ION MODE | FA170 | 1605.842045 | intensity | Wild-type | LPS |
| Reversed phase UNSPECIFIED ION MODE | FA170 | 1676.251661 | intensity | Wild-type | LPS |
| Reversed phase UNSPECIFIED ION MODE | FA170 | 1816.844085 | intensity | Wild-type | LPS+antiPla2g5 |
| Reversed phase UNSPECIFIED ION MODE | FA170 | 2043.115841 | intensity | Wild-type | LPS |
| Reversed phase UNSPECIFIED ION MODE | FA170 | 2065.719842 | intensity | Wild-type | LPS+antiPla2g5 |
| Reversed phase UNSPECIFIED ION MODE | FA170 | 2123.768127 | intensity | Wild-type | LPS+antiPla2g5 |
| Reversed phase UNSPECIFIED ION MODE | FA170 | 2264.419359 | intensity | Wild-type | LPS |
| Reversed phase UNSPECIFIED ION MODE | FA170 | 2274.112836 | intensity | Wild-type | LPS |
| Reversed phase UNSPECIFIED ION MODE | FA170 | 2301.685191 | intensity | Wild-type | LPS |
| Reversed phase UNSPECIFIED ION MODE | FA170 | 2335.763801 | intensity | Wild-type | LPS |
| Reversed phase UNSPECIFIED ION MODE | FA170 | 2347.199207 | intensity | Wild-type | LPS+antiPla2g5 |
| Reversed phase UNSPECIFIED ION MODE | FA170 | 2378.728696 | intensity | Wild-type | LPS+antiPla2g5 |
| Reversed phase UNSPECIFIED ION MODE | FA170 | 2773.402068 | intensity | Wild-type | LPS |
| Reversed phase UNSPECIFIED ION MODE | FA170 | 3792.917448 | intensity | Wild-type | LPS+antiPla2g5 |
| Reversed phase UNSPECIFIED ION MODE | FA170 | 4147.100708 | intensity | Wild-type | LPS+antiPla2g5 |
| Reversed phase UNSPECIFIED ION MODE | FA170 | 5361.058472 | intensity | Wild-type | LPS+antiPla2g5 |
| Reversed phase UNSPECIFIED ION MODE | FA170 | 5452.816289 | intensity | Wild-type | LPS |
| Reversed phase UNSPECIFIED ION MODE | FA170 | 5738.578333 | intensity | Wild-type | LPS+antiPla2g5 |
| Reversed phase UNSPECIFIED ION MODE | FA170 | 9546.25689 | intensity | Wild-type | LPS |
| Reversed phase UNSPECIFIED ION MODE | FA170 | 10170.41368 | intensity | Wild-type | LPS |
| Reversed phase UNSPECIFIED ION MODE | FA170 | 10819.64775 | intensity | Wild-type | LPS |
| Reversed phase UNSPECIFIED ION MODE | FA170 | intensity | Wild-type | LPS | |
| Reversed phase UNSPECIFIED ION MODE | FA170 | intensity | Wild-type | LPS+antiPla2g5 |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|